BlackRock Institutional Trust’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$30.8M	Buy	953,623 +9,689	+1%	+$323K	﹤0.01%	1649
2016 Q3	$32.3M	Buy	943,934 +39,713	+4%	+$1.56M	0.01%	1564
2016 Q2	$30.5M	Sell	904,221 -4,426	-0.5%	-$218K	0.01%	1563
2016 Q1	$48.1M	Buy	908,647 +5,903	+0.7%	+$345K	0.01%	1247
2015 Q4	$69.3M	Buy	902,744 +15,798	+2%	+$895K	0.01%	1047
2015 Q3	$36.5M	Buy	886,946 +8,662	+1%	+$531K	0.01%	1427
2015 Q2	$62.1M	Sell	878,284 -186,681	-18%	-$14.7M	0.01%	1177
2015 Q1	$94.6M	Buy	1,064,965 +137,039	+15%	+$13.9M	0.01%	962
2014 Q4	$82.3M	Sell	927,926 -6,262	-0.7%	-$592K	0.01%	989
2014 Q3	$90.5M	Sell	934,188 -44,170	-5%	-$4.3M	0.02%	910
2014 Q2	$89.9M	Buy	978,358 +80,794	+9%	+$6.15M	0.01%	953
2014 Q1	$62.8M	Buy	897,564 +31,471	+4%	+$2.14M	0.01%	1142
2013 Q4	$49.8M	Buy	866,093 +425,266	+96%	+$22.4M	0.01%	1260
2013 Q3	$21.2M	Buy	440,827 +63,186	+17%	+$2.3M	﹤0.01%	1814
2013 Q2	$11M	Buy	+377,641	New	+$10.9M	﹤0.01%	2246